10 Mar 2015

FDA Approves Unituxin™ (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 10, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved...

Download pdf

25 Feb 2015

United Therapeutics Corporation To Present At The Cowen And Company 35th Annual Healthcare Conference

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of...

Download pdf

24 Feb 2015

United Therapeutics Corporation Reports 2014 Fourth Quarter And Annual Financial Results

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31...

Download pdf

17 Feb 2015

United Therapeutics Corporation To Announce Fourth Quarter And Annual 2014 Financial Results Before Market Open On Tuesday, February 24, 2015

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2014 financial results...

Download pdf

06 Jan 2015

United Therapeutics Corporation To Present At 33rd Annual J.P. Morgan Healthcare Conference

SILVER SPRING, Md., Jan. 6, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, and Roger Jeffs, Ph.D., President...

Download pdf

31 Dec 2014

United Therapeutics Announces Signing Of Agreement For New Remodulin Delivery System

SILVER SPRING, Md., Dec. 31, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the signing of an agreement with DEKA Research & Development Corp. for the development of a potential...

Download pdf

24 Dec 2014

United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin

SILVER SPRING, Md., Dec. 24, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug...

Download pdf

17 Dec 2014

United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change

SILVER SPRING, Md., Dec. 17, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today two senior executive promotions as well as changes to Martine Rothblatt, Ph.D's compensation program.Senior...

Download pdf

13 Nov 2014

Professor Katherine J. Klein Joins The United Therapeutics Corporation Board Of Directors

SILVER SPRING, Md., Nov. 13, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Professor Katherine J. Klein, Ph.D., of The Wharton School of the University of...

Download pdf

28 Oct 2014

United Therapeutics Corporation Reports Third Quarter 2014 Financial Results

SILVER SPRING, Md., Oct. 28, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2014."We are pleased with our overall core...

Download pdf

21 Oct 2014

United Therapeutics Corporation To Announce Third Quarter 2014 Financial Results Before Market Open On Tuesday, October 28, 2014

SILVER SPRING, Md., Oct. 21, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2014 financial results before market open on Tuesday, October 28...

Download pdf

29 Aug 2014

District Court Decision Received In Remodulin Patent Case

SILVER SPRING, Md., Aug. 29, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. District Court for the District of New Jersey has ruled in its favor in the company's case...

Download pdf